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Introduction: Transcranial magnetic stimulation (TMS) research has suggested
dysfunction in cortical glutamatergic systems in adolescent depression, while proton
magnetic resonance spectroscopy (1H-MRS) studies have demonstrated deficits in
concentrations of glutamatergic metabolites in depressed individuals in several cortical
regions, including the anterior cingulate cortex (ACC). However, few studies have
combined TMS and MRS methods to examine relationships between glutamatergic
neurochemistry and excitatory and inhibitory neural functions, and none have utilized
TMS-MRS methodology in clinical populations or in youth. This exploratory study aimed
to examine relationships between TMS measures of cortical excitability and inhibition
and concentrations of glutamatergic metabolites as measured by 1H-MRS in depressed
adolescents.
Methods: Twenty-four adolescents (aged 11–18 years) with depressive symptoms
underwent TMS testing, which included measures of the resting motor threshold (RMT),
cortical silent period (CSP), short-interval intracortical inhibition (SICI), and intracortical
facilitation (ICF). Fourteen participants from the same sample also completed 1H-MRS
in a 3 T MRI scanner after TMS testing. Glutamate + glutamine (Glx) concentrations
were measured in medial ACC and left primary motor cortex voxels with a TE-optimized
PRESS sequence. Metabolite concentrations were corrected for cerebrospinal fluid
(CSF) after tissue segmentation. Pearson product-moment and Spearman rank-order
correlations were calculated to assess relationships between TMS measures and [Glx].
Results: In the left primary motor cortex voxel, [Glx] had a significant positive correlation
with the RMT. In the medial ACC voxel, [Glx] had significant positive correlations with
ICF at the 10-ms and 20-ms interstimulus intervals (ISIs).
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Conclusion: These preliminary data implicate glutamate in cortical excitatory processes
measured by TMS. Limitations included small sample size, lack of healthy control
comparators, possible age- and sex-related effects, and observational nature of the
study. Further research aimed at examining the relationship between glutamatergic
metabolite concentrations measured through MRS and the excitatory and inhibitory
physiology measured through TMS is warranted. Combined TMS-MRS methods show
promise for future investigations of the pathophysiology of depression in adults as well
as in children and adolescents.
Keywords: transcranial magnetic stimulation, proton magnetic resonance spectroscopy, depression, child and
adolescent, cortical excitability, glutamate
INTRODUCTION
Depression is common in youth, affecting 5.7% of US
adolescents aged 12–17 (Pratt and Brody, 2014). However,
the neurobiological mechanisms of depression in this age
group remain inadequately understood and may differ from
those in adults, as numerous systems with putative roles
in the pathophysiology of depression undergo significant
developmental changes (Zalsman et al., 2006). Several converging
lines of neurophysiological and neurochemical evidence point
to glutamate and γ-aminobutyric acid (GABA), respectively
the mammalian brain’s predominant excitatory and inhibitory
neurotransmitters, as central to the etiology of depression
(Krystal et al., 2002; Sanacora and Saricicek, 2007; Levinson
et al., 2010; Croarkin et al., 2011). Transcranial magnetic
stimulation (TMS) involves the induction of electric current
in the cerebral cortex by a focused magnetic field, which
permits noninvasive, in vivo investigation of excitatory and
inhibitory neural circuits mediated by glutamate and GABA.
Studies utilizing pharmacologic agents with known effects at
specific neurotransmitter receptors have helped to elucidate
the mechanisms of various single- and paired-pulse TMS
paradigms (Ziemann et al., 1996a, 2015; Siebner et al., 1998;
Werhahn et al., 1999). These include measures of cortical
excitability, such as the resting motor threshold (RMT) and
intracortical facilitation (ICF), as well as indices of cortical
inhibitory processes, such as the cortical silent period (CSP),
short-interval intracortical inhibition (SICI), and long-interval
intracortical inhibition (LICI; Hanajima and Ugawa, 2008;
Sandbrink, 2008; Wolters et al., 2008; Ziemann et al., 2015).
TMS has been utilized to investigate disturbances in excitatory
and inhibitory systems in a range of psychopathology in
adults, including depression (Steele et al., 2000; Bajbouj
et al., 2006; Lefaucheur et al., 2008; Levinson et al., 2010).
A meta-analysis of adult studies found reductions in CSP
duration and reduced SICI in adults with major depressive
disorder (MDD) compared to healthy controls, although
no consistent differences in RMT or ICF (Radhu et al.,
2013). Few studies have examined TMS measures of cortical
inhibition and facilitation in children and adolescents with
depression. However, our group previously found increased
ICF, but no differences in inhibitory measures, in children
and adolescents with MDD compared to healthy controls
(Croarkin et al., 2013). In a post hoc analysis of the same
sample, measures of depression severity showed significant
correlations with CSP duration as well as ICF (Lewis et al.,
2016). These preliminary findings suggest that children and
adolescents with depression may have distinct excitatory
and inhibitory cortical physiology compared to depressed
adults.
Proton magnetic resonance spectroscopy (1H-MRS) is a
magnetic resonance imaging (MRI) modality that allows
quantification of various compounds in live tissue, including
brain (Figure 1). Glutamate (Glu) and its related metabolite
glutamine (Gln) have overlapping peaks in the 1H-MR
spectrum. Consequently, the sum of their MR signals (Glx),
which also incorporates minor signal contributions from
GABA and glutathione, is often reported (Maddock and
Buonocore, 2012). Multiple prior studies examined 1H-MRS
measures of excitatory and inhibitory neurochemistry in
adults with mood disorders (Yildiz-Yesiloglu and Ankerst,
2006; Yüksel and Öngür, 2010). In adult studies, patients
with MDD had reductions in glutamatergic metabolites (Glx,
Glu, or both) compared to healthy controls in the anterior
cingulate cortex (ACC; Auer et al., 2000; Pfleiderer et al.,
2003; Hasler et al., 2007; Horn et al., 2010; Merkl et al.,
2011; Portella et al., 2011), other prefrontal cortical regions
(Michael et al., 2003a; Hasler et al., 2007) and anterior
temporal structures (Michael et al., 2003b; Block et al., 2009).
Conversely, in one study glutamate levels were elevated in
the occipital cortex of depressed adults (Sanacora et al.,
2004). Additionally, cortical decrements in 1H-MRS-measured
glutamatergic metabolites have been shown to normalize
with remission (Hasler et al., 2005; Taylor et al., 2009)
and with response to treatment (Michael et al., 2003a,b;
Pfleiderer et al., 2003). Several 1H-MRS studies have investigated
glutamatergic abnormalities in depressed, medication-naïve
children and adolescents (Kondo et al., 2011), finding decreases
in concentrations of Glx (Mirza et al., 2004; Rosenberg
et al., 2004) and Glu (Rosenberg et al., 2005) in the ACC,
but no decreases glutamatergic metabolites in the occipital
cortex (Mirza et al., 2004; Rosenberg et al., 2005), when
compared to healthy control youth. In summary, 1H-MRS
studies to date have yielded substantial evidence of glutamatergic
disturbances in adults with unipolar depression, particularly
in the ACC, while several adolescent studies have indicated
a similar pattern of altered glutamatergic neurochemistry in
depression.
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FIGURE 1 | Proton magnetic resonance spectrum from the anterior cingulate cortex (ACC). Spectroscopic data were acquired via a TE-optimized PRESS
sequence (TE 80 ms) at 3 T. Quantitative analysis was performed by LCModel (Provencher, 1993). Note the dominant glutamate (Glu) peak at 2.34 ppm. Also shown
are signal peaks of choline (Cho), creatine (Cr) and n-acetylaspartate (NAA).
The use of neurophysiologic TMS paradigms in conjunction
with MRS permits the assessment of relationships between
cortical circuitry functioning and brain neurochemistry
(Bestmann and Feredoes, 2013). However, to date this promising
approach has seldom been utilized. Two previous studies
have examined relationships between TMS measures of
cortical excitability and inhibition and 1H-MRS-measured
glutamate in healthy adults. Stagg et al. (2011) found that the
slope of the motor evoked potential (MEP) input-output
(I-O) curve, a TMS measure of excitability, correlated
strongly with 1H-MRS-measured [Glu] and [GABA] in the
corresponding primary motor cortex. By contrast, Tremblay
et al. (2013) found a positive correlation between motor
cortex [Glx] and CSP duration (which persisted when
controlling for GABA concentration), but the authors found
no correlation between 1H-MRS-measured [GABA] and
CSP, SICI, or LICI. Few studies have utilized combined
TMS-MRS methods in psychiatric populations, and those
that have done so typically examined treatment-induced
changes in excitatory and inhibitory neurochemistry following
repetitive transcranial magnetic stimulation (rTMS) for
depression (Croarkin et al., 2016; Dubin et al., 2016). To
our knowledge, no prior studies, either adult or pediatric,
have examined the associations between TMS measures of
excitatory and inhibitory neurophysiology and MRS-measured
glutamatergic neurochemistry in depressed individuals. The
current exploratory study aimed to investigate relationships
between concentrations of 1H-MRS-measured glutamatergic
metabolites (Glx) and TMS measures of cortical excitability
(RMT, ICF) and inhibition (CSP, SICI) in a sample of depressed
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adolescents. For 1H-MRS, a left primary motor cortical voxel
directly under the location of the TMS coil was selected to
examine glutamatergic metabolites in the stimulated region
of cortex. Another voxel was selected in the ACC, a structure
that has complex roles in the pathophysiology of mood
disorders, is often reliably studied with 1H-MRS, and has
numerous motor projections (Devinsky et al., 1995; Paus,
2001). We anticipated that TMS measures of glutamate-
mediated excitability (particularly ICF) would correlate directly
with 1H-MRS-measured [Glx] in both the ACC and motor
cortex.
MATERIALS AND METHODS
Study Design and Overview
This was a cross-sectional study of depressed, treatment-
seeking adolescents. All participants underwent diagnostic
and clinical assessments and TMS neurophysiology measures.
A subset of eligible participants underwent MRI/MRS. The
TMS measures were obtained during a single session, and
MRI/MRS was subsequently performed on the same day.
No treatment was provided as part of the study protocol,
but following completion, participants were referred for
additional care if clinically appropriate. Prior to enrollment,
the study protocol and all procedures were approved by
the Mayo Clinic institutional review board. Participants
under the age of 18 years granted written assent, and
parents or legal guardians gave written informed consent.
Participants who were 18 years of age provided written
consent.
Participants
The sample was comprised of 24 participants, aged 11–18 years,
with clinically significant depressive symptoms. All participants
were right-handed as determined by the Edinburgh Inventory
(Oldfield, 1971). Additionally, all participants were fluent in
the English language, and at least one parent or guardian also
was fluent in English. Exclusion criteria included a primary
psychiatric diagnosis other than a depressive disorder; history of
unprovoked seizures, febrile seizures, seizure disorder or family
history of epilepsy; significant positives on the TMS Adult Safety
Screen (Keel et al., 2001); implanted metal in the head or other
contraindications to MRI/MRS (of note, adolescents were eligible
for participation in the study if they had metallic orthodontic
hardware, although they were excluded from the MRI/MRS
portion of the protocol); prior brain surgery or risk for increased
intracranial pressure; pregnancy or suspected pregnancy; or
other unstable medical conditions. Additionally, participants
at risk of imminent self-harm or suicide as determined by
a study psychiatrist (CPL, JLVV, PEC) were not eligible for
participation.
Depression Severity Measures
Participants’ depressive symptoms were assessed with two
instruments. The Children’s Depression Rating Scale—Revised
(CDRS-R; Poznanski et al., 1984) is a 17-item, clinician-rated
scale that incorporates both parent- and adolescent-reported data
into composite scores for specific depressive symptoms. The
CDRS-R clinician total score is reported. The Quick Inventory
of Depressive Symptomatology—Adolescent (17 Item)—Self-
Report (QIDS-A17-SR) is a self-report version of the clinician-
rated QIDS-A17-C (Bernstein et al., 2010), a 17-item assessment
of depressive symptoms. The QIDS- A17-SR total score is
reported.
TMS Procedures and Measures
All participants underwent TMS to assess cortical inhibition
and excitability. Single- and paired-pulse stimulation paradigms
were applied to the left primary motor cortex, and measures
were obtained via surface electromyography (EMG) of the
contralateral (right) abductor pollicis brevis (APB) muscle
during TMS stimulation. Participants and research personnel
wore earplugs throughout the procedure.
Two Magstim 200 stimulators with a BiStim module
(Magstim Co. Ltd., Whitland, Wales, UK) and a figure-of-
eight electromagnetic coil (70 mm diameter for each coil
loop) were used. The coil was positioned tangentially on the
surface of the scalp, superficial to the left primary motor
cortex. In order to locate the optimal coil position, the
position was adjusted in 1-cm increments while stimulating
with single magnetic pulses and observing for the maximal
contraction of the contralateral APB while the muscle was at
rest. After determining the optimal position of the coil for
APB stimulation, pulse intensity was increased gradually until
the MEP on EMG reached at least 50 microvolts in 5 of 10
trials (Figure 2A); the intensity at which this occurred was
defined as the RMT (Rossini et al., 2015). After establishing
the RMT, other single- and paired-pulse measures were
acquired.
Paired-pulse measures involved the application of two paired
magnetic pulses in rapid succession to the left primary motor
cortex, again while the APB was at rest. For both SICI and
ICF paradigms, a subthreshold conditioning stimulus (80%
of RMT) was followed by a suprathreshold test stimulus
(calibrated to result in an MEP with a peak-to-peak amplitude
of 1 mV on EMG). The interstimulus intervals (ISIs) between
conditioning and test stimuli were 2 ms and 4 ms for the SICI
paradigm (Figure 2B) and were 10 ms, 15 ms, and 20 ms
for the ICF paradigm (Figure 2C). For both SICI and ICF,
the amplitude of the conditioned MEP occurring after the test
stimulus is expressed as a ratio to the mean unconditioned
MEP amplitude. Paired-pulse measures were obtained in a
randomized and counterbalanced fashion, with a total of
twelve trials at each ISI. MEP amplitude ratios were averaged
for each ISI.
To measure the CSP duration, participants maintained tonic,
voluntary contraction of the right APB (at 20% of maximum
contraction strength, measured by hand-held dynamometer),
during which single magnetic pulses at 140% of the RMT
were applied to the left primary motor cortex. The CSP was
recorded via EMG of the right APB following each pulse
(Figure 3). CSP duration was averaged over the 10 trials
performed.
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FIGURE 2 | Electromyography (EMG) of unconditioned, inhibited and
facilitated motor evoked potentials (MEPs). (A) Following a single
transcranial magnetic stimulation (TMS) pulse (at time = 0) to the primary
motor cortex at an intensity above the resting motor threshold (RMT), an MEP
is detected by EMG in the corresponding muscle. (B) In the short-interval
intracortical inhibition (SICI) paradigm, a subthreshold conditioning stimulus (at
time = 0) is administered to the primary motor cortex. After a 2-ms or 4-ms
interstimulus interval (4-ms shown), a second, suprathreshold test stimulus is
delivered. The resulting MEP is diminished in amplitude, i.e., inhibited. (C) In
the intracortical facilitation (ICF) paradigm, a subthreshold conditioning
stimulus (at time = 0) and a subsequent suprathreshold test stimulus are
administered to the primary motor cortex, separated by a 10-ms, 15-ms, or
20-ms interstimulus interval (15-ms shown). This results in an MEP that is
facilitated, or increased in amplitude.
At the conclusion of the TMS session, the position of
the center of the TMS coil was marked with a vitamin
E capsule, affixed to the scalp with adhesive, as a point
of reference for the primary motor cortex during the
1H-MRS scan.
TMS Measures of Cortical Inhibition
Two TMS measures that index GABAergic cortical inhibition
were obtained. SICI is induced by paired TMS pulses: an
initial, subthreshold conditioning stimulus followed 1–5 ms
later by a suprathreshold test stimulus, with a resultant
MEP that is diminished in amplitude compared to an
unconditioned MEP (Kujirai et al., 1993; Ziemann et al.,
1996b; Fisher et al., 2002; Ili´c et al., 2002). Prior research
has implicated intracortical GABAergic inhibitory circuits in
FIGURE 3 | EMG of the cortical silent period (CSP). In a muscle exhibiting
tonic motor activity (A), a single TMS pulse at 140% of the RMT (B) is
delivered to the corresponding area of the primary motor cortex. This is
followed by the CSP (C), a quiescent interval that ends with resumption of
motor activity (D).
the origins of SICI (Di Lazzaro et al., 1998; Hanajima
et al., 1998, 2003). Previous TMS-pharmacologic studies have
indicated that SICI results from GABAA receptor-mediated
neurotransmission in the motor cortex (Di Lazzaro et al.,
2000, 2005; Ili´c et al., 2002; Ziemann, 2004; Hanajima and
Ugawa, 2008; Ziemann et al., 2015), specifically those GABAA
receptors containing α2 or α3 subunits (Di Lazzaro et al.,
2007).
The CSP is an interval following a single suprathreshold
TMS pulse during which the EMG is quiescent, indicating an
interruption in voluntary motor activity (Day et al., 1989a,b;
Cantello et al., 1992). The CSP can persist as long as
300 ms, and while spinal inhibitory neurons are thought to
contribute to the first 50–75 ms, the latter portion of the
CSP is posited to be produced by inhibition of motor cortical
origin (Day et al., 1989b; Fuhr et al., 1991; Wolters et al.,
2008; Ziemann et al., 2015). Studies involving pharmacologic
agents with known effects on GABA receptors have implicated
activation of both GABAA and GABAB receptors in the
production of the CSP (Werhahn et al., 1999; Ziemann et al.,
2015).
TMS Measures of Cortical Excitability
By convention, the motor threshold is defined as the lowest
magnetic stimulus intensity at which an MEP is reliably
produced on EMG in the target muscle (Rossini et al., 2015).
The motor threshold is considered to represent excitability of
cortico-cortical neurons and their synapses onto corticospinal
neurons (Ziemann et al., 2015). The RMT is believed to
index glutamatergic synaptic activity more specifically than
the active motor threshold (AMT), which may depend to a
greater extent on corticospinal and spinal axonal excitability
(Paulus et al., 2008). Di Lazzaro et al. (2003) demonstrated that
the N-methyl-D-aspartate (NMDA) glutamatergic antagonist
ketamine causes dose-dependent reductions in the RMT,
possibly through enhancement of non-NMDA, α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
receptor-mediated fast glutamatergic neurotransmission
(Paulus et al., 2008; Ziemann et al., 2015). However, other
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NMDA antagonists such as memantine (Schwenkreis et al.,
1999) and dextromethorphan (Ziemann et al., 1998) have not
demonstrated effects on the RMT. The receptor-nonspecific
antiglutamatergic medication riluzole has been shown to
increase RMT over time (Schwenkreis et al., 2000). As
such, RMT is thought to depend largely on a combination
of both NDMA receptor and AMPA receptor-mediated
neurotransmission.
Like SICI, ICF involves pairing a subthreshold conditioning
stimulus with a suprathreshold test stimulus, albeit with a
slightly longer ISI of 7–20 ms. However, pairing TMS pulses
in this longer ISI range leads to MEPs that are increased
in amplitude (i.e., facilitated) compared to unconditioned
MEPs (Kujirai et al., 1993; Ziemann et al., 1996b, 2015; Di
Lazzaro et al., 2006; Hanajima and Ugawa, 2008). It has
been proposed that ICF originates in the motor cortex as
opposed to spinal neurons, and it is hypothesized to be caused
by a population of cortical interneurons distinct from those
responsible for SICI (Ziemann et al., 1996b; Hanajima et al.,
1998), although its mechanisms may be more complex than
those of SICI (Di Lazzaro et al., 2006). TMS-pharmacological
research has shown the ICF effect to vary with agents that
act at GABAA receptors (Ziemann et al., 1996a) as well as
with medications acting on NMDA receptors (Liepert et al.,
1997; Ziemann et al., 1998; Schwenkreis et al., 1999) and by
other glutamatergic mechanisms (Schwenkreis et al., 2000).
Although ICF is a complex phenomenon in which several
neurotransmitters are involved, it has been proposed as an index
of cortical excitability mediated predominantly by glutamatergic
neurotransmission (Hanajima and Ugawa, 2008; Ziemann et al.,
2015).
MRS Procedures and Measures
MRI and 1H-MRS Acquisition
Participants underwent structural MRI and TE-optimized proton
MRS using a method similar to that published previously
(Croarkin et al., 2016). Briefly, scans were obtained using a
General Electric 3 T Discovery MRI scanner (GE Medical
Systems, Inc., Waukesha, WI, USA) equipped with an 8-channel
head coil. Volumetric data for the cerebrospinal fluid (CSF)
correction were acquired using a FAST 3D SPGR sequence
(sagittal acquisition, TR = 7.4 ms, TE = 3.0 ms, flip angle = 8◦,
voxel 1.02 mm3 × 1.02 mm3 × 1.2 mm3). Structural MRI
scans were reviewed by a neuroradiologist (JDP) for incidental
findings.
A systematic approach to voxel positioning was followed
for all participants (Figure 4). During the TMS procedure,
a vitamin E capsule was affixed to the scalp overlying the
left APB point. For the left primary motor cortex voxel,
a set of axial oblique localizer slices were placed parallel
to the scalp/calvarium centered on the vitamin E capsule.
An 8 cm3 voxel (2 cm × 2 cm × 2 cm) was placed on
one of the oblique localizer slices such that: (1) the voxel
was centered on the vitamin E capsule; and (2) the voxel was
positioned as superficially as possible on the left precentral
gyrus such that the outer margin of the voxel did not enter
the calvarium. This region encompassed the hand knob of
the precentral gyrus (Brodmann area 4) that was presumably
interrogated with TMS. The ACC voxel was positioned as
previously described (Croarkin et al., 2016), encompassing the
pregenual ACC of both hemispheres (Brodmann areas 24a,
24b and 32). A TE-optimized PRESS sequence (PROBE-P,
TR = 2000 ms, TE = 80 ms, 128 acquisitions, 5000 Hz bandwidth,
2048 points) was used to obtain spectroscopic data for both voxel
locations.
Reconstruction and Quantification of Spectra
After acquisition, the spectroscopic imaging data were
transferred to a UNIX workstation running SAGE-IDL
(GE Medical Systems, Inc., Waukesha, WI, USA).
Visual verification of data integrity was performed, with
scans demonstrating significant artifact being excluded
from analysis. Quantitative analysis of metabolites was
performed with LCModel software (Provencher, 1993),
with the basis set provided by the vendor. A Cramér-
Rao lower bound of 20 (for measurement of error) was
used, and data with bounds higher than 20 were excluded
(Kreis, 2016).
Tissue Segmentation and CSF Correction
Anatomical image data was segmented into gray matter (GM),
white matter (WM), and CSF as previously described (Port
et al., 2008; Croarkin et al., 2016). Briefly, voxel locations were
superimposed upon the segmented anatomical data, and the
fractions of GM, WM, and CSF were summed for each imaging
pixel in the spectroscopy voxel. The fraction of CSF (FCSF) in each
spectroscopy voxel was computed and used to correct metabolite
concentrations:
[M]Corrected = [M]Measured ×
(
1
1− FCSF
)
(1)
CSF-corrected metabolite concentrations are reported in
‘‘institutional units.’’ All statistical analyses were performed
with CSF-corrected concentrations of metabolites. 1H-MRS
spectra yielded CSF-corrected concentrations of the following
metabolites in the ACC and left motor cortex voxels: creatine
(Cr), choline (Cho), n-acetylaspartate (NAA), glutamate (Glu),
and glutamate + glutamine (Glx).
Statistical Analysis
To assess relationships between TMS measures and
glutamatergic metabolite concentrations, correlation coefficients
were calculated for each TMS measure and [Glx] in each
voxel, with an α level of 0.05 (two-tailed) for significance.
Distributions of TMS measures of cortical excitability and
inhibition and 1H-MRS-measured Glx concentrations in each
voxel were assessed for normality using the Shapiro-Wilk test.
[Glx] in both voxels and all TMS neurophysiologic measures
demonstrated normal distributions by the Shapiro-Wilk test,
with the exception of the MEP amplitudes in the 2-ms SICI
paradigm (W = 0.8507, p = 0.0227) and the 20-ms ICF paradigm
(W = 0.7281, p = 0.0007). However, visual inspection of
Frontiers in Neural Circuits | www.frontiersin.org 6 November 2016 | Volume 10 | Article 98
Lewis et al. TMS Cortical Excitability and Glutamate
FIGURE 4 | Location of proton magnetic resonance spectroscopy (1H-MRS) voxels. (A) Axial localizer slice indicating the location of the midline anterior
cingulate voxel. This voxel encompasses the pregenual ACC of both cerebral hemispheres. (B) Coronal localizer slice indicating the location of the left primary motor
cortex voxel. The arrowhead indicates the vitamin E capsule which was placed directly over the abductor pollicis brevis (APB) point as determined by TMS. (C) Axial
oblique localizer slice showing another view of the left primary motor cortex voxel. The center of the voxel is located immediately beneath the vitamin E capsule,
encompassing the hand knob area of the primary motor cortex.
histograms and Q-Q plots revealed substantial skewness in many
of the distributions. In light of the small sample size and low
power to reject a null hypothesis of normality, we elected to
report both the parametric Pearson product-moment correlation
coefficient (r) and the non-parametric Spearman rank-order
correlation coefficient (ρ) for all correlations between TMS
measures and [Glx]. As this was an exploratory study aimed
at detecting signals of relationships of interest for hypothesis
generation, uncorrected p-values are reported and interpreted.
However, for the interested reader, adjustment of p-values
for multiple comparisons using the false discovery rate (FDR)
method (Benjamini and Hochberg, 1995) was performed,
and these are reported as well. JMP 10.0.0 software (SAS
Institute, Inc., Cary, NC, USA) was utilized for all statistical
analyses.
RESULTS
Participants
Twenty-four adolescents (16 female, 8 male) with a mean age of
15.2 ± 1.8 years enrolled in the study. Of these, 14 participants
(11 female, 3 male; mean age 14.7 ± 1.9 years) completed
1H-MRS procedures. Participant demographics, including mean
depression severity scores on the CDRS-R and QIDS-A17-
SR, are reported in Table 1. Fifteen participants were taking
psychotropic medications at the time of the study; this included
14 taking selective serotonin reuptake inhibitors, two taking
psychostimulants (which were held on days of TMS and 1H-
MRS testing), one taking an atypical antipsychotic agent, and
two taking sedative-hypnotics. For a full list of participants’
psychotropic medications and doses at the time of the study, see
Supplementary Table S1.
TMS and MRS Measures
Mean values and standard deviations for the TMS
measures (RMT, CSP, SICI-2, SICI-4, ICF-10, ICF-15,
and ICF-20) are reported in Table 2. In the left primary
motor cortex, mean [Glx] obtained via 1H-MRS was
11.35 ± 1.42 institutional units. In the medial ACC, mean
[Glx] was 18.45 ± 5.03. Other neural metabolite concentrations
obtained via 1H-MRS are reported in Supplementary Materials
(Table S2).
Cortical Excitability and
Inhibition—Cortical Glutamate
Relationships
Left Primary Motor Cortex
There was a significant positive correlation between RMT
and left motor cortex [Glx] (r = 0.6533, p = 0.0113;
ρ = 0.6300, p = 0.0158). Other relationships between TMS
measures and left motor cortex [Glx] were not significant
(Table 3).
Medial Anterior Cingulate Cortex
The MEP amplitude in the 10-ms ICF paradigm (ICF-10)
had a significant positive relationship with [Glx] (ρ = 0.6364,
TABLE 1 | Participant demographics.
All participants 1H-MRS participants
Sex
Female n = 16 n = 11
Male n = 8 n = 3
Age 15.2 ± 1.8 years 14.7 ± 1.9 years
Ethnicity
African-American n = 2 n = 1
African-American/Caucasian n = 1 n = 1
Asian n = 2 n = 1
Caucasian n = 17 n = 9
Hispanic n = 1 n = 1
Native American n = 1 n = 1
CDRS-R score 39.2 ± 13.0 41.5 ± 14.4
QIDS-A17-SR score 11.5 ± 5.2 11.9 ± 5.9
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TABLE 2 | Excitatory and inhibitory TMS measures.
All participants 1H-MRS participants
RMT 60.79 ± 11.94 60.43 ± 11.75
CSP 0.190 ± 0.051 s 0.194 ± 0.061 s
SICI-2 0.440 ± 0.314 0.495 ± 0.358
SICI-4 0.578 ± 0.296 0.474 ± 0.279
ICF-10 1.568 ± 0.465 1.455 ± 0.367
ICF-15 1.765 ± 0.447 1.681 ± 0.413
ICF-20 2.299 ± 0.699 2.472 ± 0.698
Abbreviations: RMT, resting motor threshold; CSP, cortical silent period; SICI-2, -4,
short-interval intracortical inhibition at 2-ms and 4-ms interstimulus intervals,
respectively; ICF-10, -15, -20, intracortical facilitation at 10-ms, 15-ms and
−20-ms interstimulus intervals, respectively. RMT is expressed as a percentage
of maximal device output. MEP amplitudes in the SICI and ICF paradigms are
expressed as ratios to the mean unconditioned stimulus amplitude.
p = 0.0261) in the medial ACC. Additionally, the MEP amplitude
in the 20-ms ICF paradigm (ICF-20) demonstrated a significant
positive correlation with [Glx] (r = 0.7201, p = 0.0083).
Correlations between ACC [Glx] and other TMS measures were
not significant (Table 3).
DISCUSSION
This was an exploratory study investigating the potential
link between glutamatergic neurochemistry and excitatory and
inhibitory neurophysiology. To our knowledge, this was the
first study to examine relationships between 1H-MRS-measured
concentrations of neural metabolites and TMS measures of
cortical excitation and inhibition in a psychiatric population, as
well as the first to characterize these relationships in adolescents.
Additionally, unlike prior TMS-MRS studies, neural metabolite
concentration values were corrected to CSF. This eliminates the
potential distortion that may be caused by correcting values to
creatine, whose concentration may be altered in pathological
conditions (Maddock and Buonocore, 2012) and indeed has been
found to differ in adults with mood disorders (Frye et al., 2007;
Port et al., 2008) as well as adolescents with MDD (Gabbay et al.,
2007) and other psychopathology (Mirza et al., 2006).
Motor Cortex Glutamate and Cortical
Excitability
The question of whether properties of TMS-induced MEPs
originating in the primary motor cortex correspond to
neurotransmitter levels in the same region of cortex is
intuitive, and indeed these relationships have been the
focus of two prior studies in healthy adults and one study
in adults with mild brain injury. Stagg et al. (2011) investigated
the relationships of GABA and glutamate concentrations in
the motor cortex to various TMS measures of excitability
and inhibition. The authors found that the MEP I-O curve,
considered to be a global measure of excitability, was
positively correlated with both motor cortex glutamate and
motor cortex GABA concentrations; however, the MEP
I-O—glutamate relationship did not survive correction for
GABA concentration. In another study, Tremblay et al.
(2013) noted a significant positive association between the
CSP duration and motor cortex [Glx], a relationship that
remained significant after controlling for GABA concentration.
No significant correlations between 1H-MRS-measured
[GABA] and CSP, SICI, or LICI were found. In another
study, Tremblay et al. (2014) found a correlation between
LICI and motor cortex [GABA] in young adult athletes with
histories of concussion, a relationship that was absent in
healthy control comparators, suggesting potential alterations
in GABA-mediated inhibitory physiology due to brain
pathology.
In the present study, we found a strong correlation
between the RMT and motor cortex [Glx]. Interestingly,
the relationship was positive (i.e., higher levels of [Glx]
corresponded to higher thresholds for evoked potentials),
which is somewhat counterintuitive and also differs from
the direction of the relationship between RMT and ACC
glutamate concentration (which did not quite meet the threshold
for significance). Numerous factors could account for this.
The physiology of the RMT is complex; both cortico-cortical
and corticospinal neurons are involved (Sandbrink, 2008),
and both voltage-gated sodium channels and glutamatergic
receptors have been demonstrated to mediate the threshold
level (Ziemann et al., 2015). The RMT may best be described
TABLE 3 | Correlations between 1H-MRS-measured glutamatergic metabolite concentrations and TMS measures of cortical excitability and inhibition.
Left primary motor cortex [Glx] Medial anterior cingulate cortex [Glx]
Pearson r p pFDR Spearman ρ p pFDR Pearson r p pFDR Spearman ρ p pFDR
RMT 0.6533 0.0113∗ 0.0791 0.6300 0.0158∗ 0.1827 −0.4027 0.1943 0.3022 −0.5149 0.0867 0.2616
CSP −0.0635 0.8293 0.8931 −0.1824 0.5325 0.6777 −0.1373 0.6704 0.8532 −0.2657 0.4038 0.5653
SICI-2 0.0990 0.7363 0.8590 0.0725 0.8054 0.8403 0.4414 0.1508 0.2639 0.4615 0.1309 0.2618
SICI-4 0.5093 0.0629 0.2639 0.4593 0.0985 0.2616 −0.1504 0.6408 0.8532 −0.1469 0.6488 0.7569
ICF-10 −0.4123 0.1429 0.2639 −0.4901 0.0752 0.2616 0.4742 0.1193 0.2639 0.6364 0.0261∗ 0.1827
ICF-15 0.0045 0.9879 0.9879 −0.0593 0.8403 0.8403 −0.4753 0.1184 0.2639 −0.4825 0.1121 0.2616
ICF-20 −0.4704 0.0896 0.2639 −0.3890 0.1692 0.2961 0.7201 0.0083∗ 0.0791 0.4056 0.1908 0.2968
∗p < 0.05. Abbreviations: [Glx], glutamate+glutamine; RMT, resting motor threshold; CSP, cortical silent period; SICI-2, -4, short-interval intracortical inhibition at 2-ms
and 4-ms interstimulus intervals, respectively; ICF-10, -15, -20, intracortical facilitation at 10-ms, 15-ms and 20-ms interstimulus intervals, respectively; pFDR, p-value
corrected for multiple comparisons by the false discovery rate procedure.
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as a global index of cortical and spinal excitability that has
many inputs, including glutamate-mediated neurotransmission.
Thus, it perhaps would be overly simplistic to assume that
an increase in glutamate necessarily leads to a decrease in
RMT, as autoregulatory feedback loops and other mechanisms
may mediate the effect of local glutamate concentration
on the RMT. Furthermore, concentrations of glutamate or
glutamate + glutamine in a region of cortex may not be
particularly accurate indices of the pool of glutamate available
for excitatory functions. Vesicular glutamate is not well
detected by 1H-MRS, and the concentrations measured by
the current spectroscopic techniques may better represent the
total neuronal and glial stores of glutamate and glutamine
available for both synaptic and metabolic functions (Yüksel
and Öngür, 2010; Maddock and Buonocore, 2012). Magnetic
fields greater than the 3 T employed for 1H-MRS in this
study are necessary to separate signals for glutamine and
glutamate reliably. Additionally, there is growing recognition
of the role of neuroactive chemicals in the extracellular matrix
on intercellular communication in the brain (Marcoli et al.,
2015). Nevertheless, it is notable that glutamatergic metabolites
in the primary motor cortex demonstrated associations with
the RMT, and further research is necessary to characterize
the mechanisms by which glutamate mediates this aspect of
excitatory physiology.
ACC Glutamate and Cortical Excitability
The few prior studies that examined relationships between
TMS measures of cortical excitability and inhibition and
cortical glutamatergic concentrations selected 1H-MRS
voxels only in the motor cortex. There is robust evidence
from prior 1H-MRS studies that glutamate metabolism in
the ACC is disrupted in youth with MDD (Mirza et al.,
2004; Rosenberg et al., 2004, 2005; Kondo et al., 2011),
but it is not clear what effect this has on physiologic
functions mediated by the motor cortex. Consequently,
we investigated the relationships between ACC glutamate
concentrations and TMS measures of cortical excitability and
inhibition.
ACC [Glx] did not demonstrate significant correlations
with inhibitory measures (CSP, SICI). However, [Glx] did
demonstrate a strong positive correlation with MEP amplitude
in the 10-ms ICF paradigm (in nonparametric correlations) and
in the 20-ms paradigm (parametric), with higher concentrations
of glutamate in the ACC corresponding to greater facilitation
of the MEP. One should be cautious in assuming that
increases in excitatory neurotransmitters in one area of
cortex necessarily lead to increased excitatory physiology
in another region. Nonetheless, these findings suggest that
increased glutamate (or increased glutamate + glutamine
stores) in the ACC may have downstream effects on the
excitatory physiology mediated by the motor cortex, which
is plausible in light of the dense connectivity between these
two cortical regions (Paus, 2001). Replication, particularly in
healthy control adolescents, would help to establish such a
relationship. It is unclear why the nonsignificant ICF-ACC
glutamate correlation was negative at the 15-ms ISI, but this
could be related to subtle differences in the physiology of
facilitatory responses at different ISIs, something that has been
observed with GABA-mediated SICI paradigms (Fisher et al.,
2002; Ili´c et al., 2002; Hanajima et al., 2003; Stagg et al.,
2011).
In contrast to these ICF findings, the correlation between
ACC glutamate and the RMT, which did not quite reach
significance, was negative. This differs from the statistically
significant, positive correlation between the RMT and [Glx] in
the primary motor cortex. The negative relationship observed
between glutamate concentrations in the ACC and the RMT
could be related to glutamate-mediated regulatory circuits
between the ACC and the motor cortex. As noted above, the
physiology of the RMT involves many elements, notably the
voltage-gated sodium channels, and it is possible that within
the motor cortex these dominate the excitability responsible for
motor threshold, with glutamate playing a lesser role. Future
studies investigating the relationship between ACC glutamate
and TMS measures of cortical excitability in healthy adolescent
populations may help to understand the excitatory physiology of
ACC-motor cortex connections further.
Limitations
The current study has several notable limitations. First, the
sample size was small, particularly the subset that completed
both TMS and 1H-MRS procedures. Although similar in size to
the few previous TMS-MRS studies, this limited our statistical
approaches. Correlations that were significant based on raw
p-values did not survive correction for multiple comparisons,
which is unsurprising in light of the number of correlations
performed and the small number of participants. Thus, the
findings should be interpreted with caution. Larger studies with
greater power are warranted, particularly as this could permit
controlling for potential confounds. Additionally, the sample
did not include healthy controls. In the absence of data from
healthy youth, it is not possible to determine to what extent
depression may impact these findings, and future studies should
endeavor to compare healthy participants and participants
with psychopathology. The participants in this study were not
medication-naïve, unlike many of the previous studies utilizing
1H-MRS or TMS methods. Although concurrent psychotropic
medications or history of pharmacologic interventions do pose
potential confounds, the sample of our study is potentially more
representative of populations seen in typical clinical practice. An
additional potential confound is the impact of the menstrual
cycle on both TMS and 1H-MRS data, particularly as the sample
was comprised predominantly of female adolescents. Prior TMS
research has shown cortical inhibition to increase during the
luteal phase in healthy women (Smith et al., 1999, 2003) but
to decrease in women with premenstrual dysphoria (Smith
et al., 2003), and 1H-MRS studies have shown alterations in
cortical GABA levels across the menstrual cycle (Epperson et al.,
2002, 2005; Harada et al., 2011). While menstrual phase and
sex hormone levels were not assessed in the female adolescent
participants in the present study, future investigations should
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consider the value of additional measures to assess and control
for sex- and menstrual-related effects.
Previous research has established that significant changes
occur in excitatory and inhibitory circuitry systems during
the childhood and adolescent years. In early life, expression
of various subunits that compose GABAA receptors has been
found to change over time (Duncan et al., 2010), while GABAA
receptor density changes at differing rates in various brain
regions into adulthood (Chugani et al., 2001). GABA receptors
also show paradoxically excitatory activity in early childhood,
with a gradual shift toward inhibition with age (Rakhade and
Jensen, 2009). Glutamatergic neurotransmission also undergoes
developmental shifts, including alterations in expression of
glutamatergic receptor types, as well as modifications in receptor
subunit composition affecting ion permeability (Silverstein
and Jensen, 2007). In the TMS literature, one of the most
consistent age-related findings is that the RMT diminishes
with increasing age, both in neurologically- and psychiatrically-
healthy individuals (Nezu et al., 1997; Heinen et al., 1998;
Moll et al., 1999; Garvey et al., 2003; Mall et al., 2004; Gilbert
et al., 2011) as well as those with conditions such as attention-
deficit/hyperactivity disorder (Gilbert et al., 2011), Tourette
syndrome (Moll et al., 2006), and MDD (Croarkin et al., 2014).
The impact of age on inhibitory TMS measures is less clear,
with some studies finding CSP duration (Heinen et al., 1998;
Moll et al., 1999), SICI (Mall et al., 2004), and LICI (Croarkin
et al., 2014) to increase with age, while others have found no
significant relationship with age for CSP (Garvey et al., 2003;
Gilbert et al., 2011; Croarkin et al., 2014) or SICI (Moll et al.,
1999; Gilbert et al., 2004, 2011; Croarkin et al., 2014). The
statistical methods of the present study do not permit controlling
for age; however, future studies utilizing neurophysiologic TMS
in children and adolescents could consider regression analyses
with age as a covariate. Further research is warranted to
characterize more conclusively the developmental trajectories of
TMS-measured cortical excitability and inhibition in the context
of MDD.
In the processing of 1H-MRS data, there are inherent
challenges in separating signals for Glu, Gln and GABA. Our
1H-MRS procedures did not permit identification of a distinct
GABA signal, in contrast to other TMS-MRS studies (Stagg
et al., 2011; Tremblay et al., 2013, 2014). However, there is
significant interaction between GABAergic and glutamatergic
systems, both at the level of their neurochemical pathways
and in the excitatory-inhibitory balance achieved by circuits
of GABAergic and glutamatergic neurons. Additionally, the
interpretation of glutamatergic metabolite concentration data
is difficult, as 1H-MRS-measured concentrations reflect the
combined neuronal and glial stores of glutamate and glutamine,
and also are believed to represent primarily cytoplasmic
(as opposed to mitochondrial or vesicular) concentrations
(Maddock and Buonocore, 2012). While total quantities of
glutamatergic metabolites would be expected to influence
glutamate-mediated (and GABA-mediated) processes, neuronal
vesicular glutamate concentrations may be more immediately
related to the neurotransmission underlying the excitatory
and inhibitory phenomena measured by TMS. Moreover, the
spectroscopic data were obtained at a single point in time. This
is relevant in light of evidence from human 1H-MRS studies
in which glutamatergic metabolites have been demonstrated to
fluctuate in response to sensory stimuli (Mullins et al., 2005;
Mangia et al., 2007; Gussew et al., 2010) and physical activity
(Maddock et al., 2011), suggesting that glutamate concentrations
are state-dependent and dynamic (Maddock and Buonocore,
2012). Although the 1H-MRS data in the present study were
obtained on the same day as TMS testing, they were not
concurrent with the excitatory and inhibitory processes induced
by TMS.
CONCLUSION
The preliminary evidence from this small study supports the role
of glutamate in cortical excitatory processes that are measured
by TMS. To our knowledge, this was the first study to utilize the
combination of TMS and 1H-MRS in a psychiatric population
as well as the first to do so with adolescents. Further research
aimed at examining the relationships between glutamatergic
metabolite concentrations measured by MRS and excitatory and
inhibitory physiology measured by TMS is warranted. Combined
TMS-MRS methods have potential utility for investigating
developmental changes in excitatory and inhibitory processes
in healthy youth, studying the pathophysiology of common
neurodevelopmental psychiatric conditions such as MDD, and
ultimately for the development of biomarkers in children and
adolescents.
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